Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy (CRT) in muscle-invasive urothelial carcinoma of bladder (MIBC): A combined retrospective analysis of two prospective studies.

被引：0
|
作者：
Hong, Joohyun
Choi, Daeho
Sung, Hyun Hwan
Jeong, Byong Chang
Park, Se Hoon
机构：
[1] Sungkyunkwan Univ, Div Hematol Oncol, Dept Internal Med, Samsung Med Ctr,Sch Med, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
496
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer
    Osterman, Chelsea K.
    Babu, Dilip S.
    Geynisman, Daniel M.
    Lewis, Bianca
    Somer, Robert A.
    Balar, Arjun V.
    Zibelman, Matthew R.
    Guancial, Elizabeth A.
    Antinori, Gianna
    Yu, Shun
    Narayan, Vivek
    Guzzo, Thomas J.
    Plimack, Elizabeth R.
    Vaughn, David J.
    Fung, Chunkit
    Mamtani, Ronac
    ONCOLOGIST, 2019, 24 (05): : 688 - 690
  • [32] Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
    Fairey, Adrian S.
    Daneshmand, Siamak
    Quinn, David
    Dorff, Tanya
    Dorin, Ryan
    Lieskovsky, Gary
    Schuckman, Anne
    Cai, Jie
    Miranda, Gus
    Skinner, Eila C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (08) : 1737 - 1743
  • [33] Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility
    Schinzari, Giovanni
    Monterisi, Santa
    Pierconti, Francesco
    Nazzicone, Giulia
    Marandino, Laura
    Orlandi, Armando
    Racioppi, Marco
    Cassano, Alessandra
    Bassi, Pierfrancesco
    Barone, Carlo
    Rossi, Ernesto
    ANTICANCER RESEARCH, 2017, 37 (11) : 6453 - 6458
  • [34] COMPARATIVE EFFECTIVENESS OF SELECTIVE ADJUVANT VERSUS SYSTEMATIC NEOADJUVANT CHEMOTHERAPY-BASED STRATEGY FOR MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Seisen, Thomas
    Sonpavde, Guru
    Kachroo, Naveen
    Lipsitz, Stuart R.
    Leow, Jeffrey J.
    Menon, Mani
    Gild, Philipp
    von Landenberg, Nicolas
    Roupret, Morgan
    Kibel, Adam S.
    Sun, Maxine
    Pal, Sumanta K.
    Bellmunt, Joaquim
    Choueiri, Toni K.
    Quoc-Dien Trinh
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1193 - E1193
  • [35] Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?
    Tachibana, Isamu
    Bandali, Elhaam
    Calaway, Adam C.
    Krishnan, Naveen
    Cheng, Liang
    Adra, Nabil
    Kaimakliotis, Hristos Z.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (11) : 850.e1 - 850.e7
  • [36] Defining molecular and laboratory predictive biomarkers of response to cisplatin-based neoadjuvant chemotherapy (NC) in muscle-invasive bladder cancer (MIBC) - preliminary results and future plans
    Leibowitz-Amit, Raya
    Seah, Jo-An
    Berger, Raanan
    Sridhar, Srikala S.
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Identification of molecular biomarkers of cisplatin-based chemosensitivity in patients undergoing neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Shah, Paras Hemant
    Lee, Annette
    Zhu, Xinhua
    Bradley, Thomas Paul
    Vira, Manish Arvind
    Korsunsky, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [38] Molecular features underlying response to neoadjuvant gemcitabine, cisplatin, and sorafenib (S-GC) in muscle-invasive urothelial bladder carcinoma (MIBC): Insights for trials of new agents combined with chemotherapy in the field
    Necchi, Andrea
    Raggi, Daniele
    Busico, Adele
    De Cecco, Loris
    Giannatempo, Patrizia
    Nicolai, Nicola
    Piva, Luigi
    Biasoni, Davide
    Catanzaro, Mario
    Torelli, Tullio
    Stagni, Silvia
    Calareso, Giuseppina
    Togliardi, Elena
    Colecchia, Maurizio
    Mariani, Luigi
    Salvioni, Roberto
    Paoli, Alessandro
    Daidone, Maria Grazia
    Sensi, Marialuisa
    Perrone, Federica
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study
    Elkarta, Ahmed
    Awadalla, Amira
    El-hefnawy, Ahmed
    Mosbah, Ahmed
    Abolenein, Hassan
    Shokeir, Ahmed
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 38 - 46.e1
  • [40] Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC).
    Miron, Benjamin
    Ross, Eric A.
    Anari, Fern
    O'Neill, John
    Hoffman-Censits, Jean H.
    Zibelman, Matthew R.
    Kutikov, Alexander
    Viterbo, Rosalia
    Greenberg, Richard E.
    Chen, David
    Lallas, Costas D.
    Trabulsi, Edouard John
    Alpaugh, R. Katherine
    Dulaimi, Essel
    Golemis, Erica
    Uzzo, Robert
    Plimack, Elizabeth R.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345